Stoneridge Investment Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,200	Closed	-$628K	–	129
2024 Q1	$628K	Buy	+4,200	New	+$628K	0.24%	80